Injecting drug users and the Human Immunodeficiency Virus: what do we know?

References

• Des Jarlais DC, Friedman SR, Casriel C. Target groups for preventing AIDS among intravenous drug users: 2. The hard data studies. J Consult Clin Psychol 1990; 58: 50–56
   PubMed Web of Science ®Google Scholar
• World Health Organization and the Centers for Disease Control. Statistics from the World Health Organization and the Centers for Disease Control. AIDS 1991; 5: 1399–1403
   PubMedGoogle Scholar
• National Centre in AIDS Epidemiology and Clinical Research. Cumulative analysis of AIDS cases in Australia. 1991
   Google Scholar
• Morlet A, Darke S, Guinan JJ, Wolk J, Gold J. Intravenous drug users who present to the Albion St (AIDS) Centre for diagnosis and management of human immunodeficiency virus infection. Med J Aust 1990; 152: 78–80
   PubMed Web of Science ®Google Scholar
• Ross MW, Gold J, Wodak AD, Miller ME. Sexually transmissible diseases in injecting drug users. Genitourin Med 1991; 67: 32–36
   PubMedGoogle Scholar
• Des Jarlais, DC, Friedman, SR, Novick, DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989; 261: 1008–1012
   PubMed Web of Science ®Google Scholar
• Titti F, Lazzarin A, Costigliola P, Oliva C, Nicoletti L, Negri C. Human Immunodeficiency Virus (HIV) seropositivity in intravenous (IV) drug abusers in three cities of Italy: possible natural history of HIV infection in HIV infection in IV drug addicts in Italy. J Med Viro 1987; 23: 241–248
   PubMedGoogle Scholar
• Robertson JR, Skidmore CA, Roberts JJK. HIV infection in intravenous drug users: a follow-up study indicating changes in HIV risk-taking behaviour. Br J Addict 1988; 83: 387–391
   PubMedGoogle Scholar
• Choopanya, K, Vanichseni, S, Des Jarlais, DC, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS 1991; 5: 1509–1513
   PubMed Web of Science ®Google Scholar
• Chiasson MA, Stoneburner RL, Hildebrandt DJ, Ewing WE, Telzak EE, Jaffe HW. Heterosexual tramission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 1991; 5: 1121–1126
   PubMed Web of Science ®Google Scholar
• Turner CF, Miller HG, Moses LE. AIDS. Sexual Behaviour and intravenous drug use. National Academy Press, Washington, DC 1989
   Google Scholar
• Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989; 261: 561–565
   PubMed Web of Science ®Google Scholar
• Friedland G. Parenteral drug users. The epidemiology of AIDS. Expression, occurrence and control of Human Immunodeficiency Virus type 1 infection, RA Kaslow, DP Francis. Oxford University Press, New York 1989; 153–178, In
   Google Scholar
• Friedman SR, Des Jarlais DC. HIV among injecting drug users: the epidemic and the response. AIDS Care 1991; 3: 239–250
   PubMedGoogle Scholar
• Celantano D, Vlahov D, Cohn S, Anthony JC, Soloman L, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health 1991; 81: 1291–1306
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Friedman SR. Shooting galleries and AIDS: infection probabilities and ‘tough’ policies. Am J Public Health 1990; 80: 142–144
   PubMed Web of Science ®Google Scholar
• Vlahov D, Munoz A, Anthony JC, Cohn S, Celantano D, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus, type 1 among IVDUs in Baltimore. Am J Epidemiol 1990; 132: 847–856
   PubMed Web of Science ®Google Scholar
• Chitwood, DD, McCoy, CB, Inciardii, JA, et al. HIV seropositivity of needles from shooting galleries in South Florida. Am J Public Health 1990; 80: 150–152
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Friedman SR. HIV infection among persons who inject illicit drugs: problems and prospects. JAIDS 1988; 1: 267–273
   Google Scholar
• Van den Hoek JAR, Coutinho RA, van Haarstrecht HJA, Zadelhoff AW, Goudsmit J. Prevalence and risk factors for HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988; 2: 55–60
   PubMed Web of Science ®Google Scholar
• Van den Hoek JAR, van Haarstrecht HJA, Scheeringa-Troost B, Goudsmit J, Coutinho RA. HIV infection and STD in drug addicted prostitutes in Amsterdam: potential for heterosexual HIV transmission. Genitourin Med 1989; 65: 146–150
   PubMedGoogle Scholar
• Peach H, Heller RF. Epidemiology of common disease. Heineman, London 1984
   Google Scholar
• Batki SL, Sorenson JL, Gibson DR, Maude-Triffin P. HIV infected IV drug users in methadone treatment: outcome and psychological correlates. A preliminary report. Problems of drug dependence 1989, LS Harris. Natl Inst Drug Abuse Res Monogr Ser 95, 1989; 405–406, In
   Google Scholar
• Darke S, Baker A, Dixon J, Wodak A, Heather N. Drug use and HIV risk-taking behaviour among clients in methadone maintenance treatment. Drug Alcohol Depend 1992; 29: 263–268
   PubMed Web of Science ®Google Scholar
• Klee H, Faugier J, Hayes C, Boulton T, Morris J. AIDS-related risk behaviour, polydrug use and temazepam. Br J Addict 1990; 85: 1125–1132
   PubMedGoogle Scholar
• Metzger D, Woody G, DePhilipis D, McLellan AT, O'Brien CP, Platt JJ. Risk factors for needle sharing among methadone treated patients. Am J Psychiatry 1991; 48: 636–640
   Google Scholar
• Torrens M, San L, Peri JM, Olle JM. Cocaine abuse among heroin addicts in Spain. Drug Alcohol Depend 1991; 27: 29–34
   PubMed Web of Science ®Google Scholar
• Nemoto T, Brown LS, Primm BJ, Foster K, Chu A. Mode of transmission among seroconverted intravenous drug users (IVDUs): 1987 and 1988 cohort study. Problems of drug dependence 1989, LS Harris. Natl Inst Drug Abuse Res Monogr Ser 95, 1989; 407–408, In
   Google Scholar
• Mascola, L, Lieb, L, Iwakoshi, KA, et al. HIV seroprevalence in intravenous drug users. LA, California, 1986. Am J Public Health 1989; 79: 81–82
   PubMed Web of Science ®Google Scholar
• Dolan MP, Black JC, Deford HA, Skinner JR, Robiniwitz R. Characteristics of drug abusers that discriminate needle sharers. Pub Health Rep 1987; 102: 395–398
   PubMed Web of Science ®Google Scholar
• Nemoto T, Brown LS, Foster K, Chu A. Behavioural risk factors for human immunodeficiency virus infection among intravenous drug users and implications for preventative interventions. AIDS Ed Prevent 1990; 2: 116–126
   PubMedGoogle Scholar
• Darke S, Hall W, Carless J. Drug use, injecting practices, and sexual behaviour of opioid users in Sydney, Australia. Br J Addict 1990; 85: 1603–1609
   PubMedGoogle Scholar
• Darke S, Wodak A, Hall W, Heather N, Ward J. Prevalence and predictors of psychopathology among opioid users. Br J Addict 1992; 87: 771–776
   PubMedGoogle Scholar
• Rounsaville BJ, Kosten T, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts. A 2.5 year follow-up study. Arch Gen Psychiatry 1986; 43: 739–745
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ, Weissman MM, Kleber HD, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982; 39: 161–166
   PubMed Web of Science ®Google Scholar
• Strain EC, Brooner RK, Bigelow GE. Clustering of multiple substance use and psychiatric diagnoses in opiate addicts. Drug Alcohol Depend 1991; 27: 127–134
   PubMed Web of Science ®Google Scholar
• Swift W, Williams G, Neill O, Grenyer B. The prevalence of minor psychopathology in opioid users seeking treatment. Br J Addict 1990; 85: 629–634
   PubMedGoogle Scholar
• Woody GE, McLellan AT, Luborsky L, O'Brien CP. Twelve-month follow-up of psychotherapy for opiate dependence. Am J Psychiatry 1987; 144: 590–596
   PubMed Web of Science ®Google Scholar
• Brooner RK, Bigelow GE, Strain E, Schmidt CW. Intravenous drug abusers with anti-social personality disorder: increased HIV risk behaviour. Drug Alcohol Depend 1990; 26: 39–44
   PubMed Web of Science ®Google Scholar
• Nolimal D, Crowley TJ. HIV risk behaviour: Anti-social Personality Disorder, drug use patterns and sexual behaviour among methadone maintenance admissions. Problems of drug dependence 1989, LS Harris. Natl Inst Drug Abuse Res Monogr Ser 95, 1989; 401–402, In
   Google Scholar
• Khantzian EJ, Treece C. Psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry 1985; 42: 1067–1071
   PubMed Web of Science ®Google Scholar
• Woody GE, McLellan AT, Luborsky L, O'Brien CP. Sociopathy and psychotherapy outcome. Arch Gen Psych 1985; 42: 1081–1086
   PubMed Web of Science ®Google Scholar
• Donoghoe MC, Stimson G, Dolan KA. Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners. AIDS Care 1989; 1: 51–58
   PubMedGoogle Scholar
• Feucht TE, Stephens RC, Roman SW. The sexual behaviour of intravenous drug users: assessing the risk of the sexual transmission of HIV. J Drug Issues 1990; 20: 195–213
   Web of Science ®Google Scholar
• Klee H, Faugier J, Hayes C, Boulton T, Morris J. Sexual partners of injecting drug users: the risk of HIV infection. Br J Addict 1990; 85: 413–418
   PubMedGoogle Scholar
• Sasse H, Salmaso S, Conti S, the First Drug User Multicentre Study Group. Risk behaviours for HIV-1 in Italian drug users: report from a multicentre study. JAIDS 1989; 2: 486–496
   Google Scholar
• Sasse H, Salmaso S, Conti S, the First Drug User Multicentre Study Group. Sexual lifestyles in injecting drug users in Italy: potential for HIV infection transmission. Br J Addict 1991; 86: 1083–1089
   PubMedGoogle Scholar
• Des Jarlais, DC, Wish, E, Friedman, SR, et al. Intravenous drug users and the sexual transmission of the acquired immunodeficiency syndrome. NY State J Med 1987; 87: 283–286
   PubMedGoogle Scholar
• Philpot CR, Harcourt CL, Edwards JM. Drug use by prostitutes in Sydney. Br J Addict 1989; 84: 499–505
   PubMedGoogle Scholar
• Saxon AJ, Calsyn DA, Whittaker S, Freeman G. Sexual behaviours of intravenous drug users in treatment. JAIDS 1991; 4: 938–944
   Google Scholar
• Van den Hoek JAR, van Haastrecht HJA, Coutinho RA. Heterosexual behaviour of intravenous drug users in Amsterdam: implications for the AIDS epidemic. AIDS 1990; 4: 449–453
   PubMed Web of Science ®Google Scholar
• Schoenbaum, EE, Hartel, D, Selwyn, PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl J Med 1989; 321: 874–879
   PubMed Web of Science ®Google Scholar
• Cohen JB, Haver LB, Wofsey CB. Women and intravenous drugs: parenteral and heterosexual transmission of Human Immunodeficiency Virus. J Drug Issues 1989; 19: 39–56
   Web of Science ®Google Scholar
• Gossop M, Griffiths P, Strang J. Chasing the dragon: characteristics of heroin chasers. Br J Addict 1989; 83: 1159–1162
   Google Scholar
• McKeganey N, Barnard M, Watson H. HIV-related risk behaviours among a non-clinic sample of injecting drug users. Br J Addict 1988; 84: 1481–1490
   Google Scholar
• Klee H. A new target for behavioural research—amphetamine misuse. Br J Addict 1992; 87: 439–446
   PubMedGoogle Scholar
• Rolfs RT, Goldberg M, Sharrer RG. Risk factors for syphilis: cocaine use and prostitution. Am J Public Health 1990; 80: 853–857
   PubMed Web of Science ®Google Scholar
• Greenbladh, RM, Lukehart, SA, Plummer, FA, et al. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 1988; 2: 47–50
   PubMedGoogle Scholar
• Pepin, J, Plummer, FA, Brunham, RC, et al. The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention. AIDS 1989; 3: 3–9
   PubMed Web of Science ®Google Scholar
• Simonsen, JN, Cameron, W, Gakinya, MN, et al. Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a centre in Africa. N Engl J Med 1988; 319: 274–278
   PubMed Web of Science ®Google Scholar
• Ross MW, Wodak A, Gold J. Sexual behaviour in injecting drug users. J Psychol Human Sexuality 1991; 4, in press
   Google Scholar
• Sibthorpe B, Fleming D, Tesselaar H, Gould J. Needle use and sexual practices: differences in perception of personal risk of HIV among intravenous drug users. J Drug Issues 1991; 21: 699–712
   Web of Science ®Google Scholar
• Celentano DD, Vlahov D, Menon AS, Polk BF. HIV knowledge and attitudes among intravenous drug users: comparisons to the US population and by drug use behaviours. J Drug Issues 1991; 21: 635–649
   Web of Science ®Google Scholar
• Magura, S, Grossman, JI, Lipton, DS, et al. Determinants of needle sharing among intravenous drug users. Am J Public Health 1989; 79: 459–462
   PubMed Web of Science ®Google Scholar
• Ottomanelli G, Kramer TH, Bihari B, Fine J, Heller S, Mosely JA. AIDS-related risk behaviours among substance abusers. Int J Addict 1990; 25: 291–299
   PubMed Web of Science ®Google Scholar
• Stimson GV, Donoghoe LA, Dolan K. HIV transmission risk behaviour of clients attending needle exchange schemes in England and Scotland. Br J Addict 1988; 83: 1449–1455
   PubMedGoogle Scholar
• Klee H, Faugier J, Hayes C, Boulton T, Morris J. Factors associated with risk behaviour among injecting drug users. AIDS Care 1990; 2: 133–145
   PubMedGoogle Scholar
• Klee H, Faugier J, Hayes C, Morris J. The sharing of injecting equipment among users attending prescribing clinics and those using needle exchanges. Br J Addict 1991; 86: 217–223
   PubMedGoogle Scholar
• Wolk J, Wodak A, Morlet A, Guinan JJ, Gold J. HIV-related risk-taking behaviour, knowledge and serostatus of intravenous drug users in Sydney. Med J Aust 1990; 152: 453–458
   PubMed Web of Science ®Google Scholar
• Abdul-Quader AS, Friedman SR, Des Jarlais DC, Marmor MM, Maslansky R, Bartelme S. Methadone maintenance and behaviour by intravenous drug users that can transmit HIV. Contemporary Drug Problems 1987; 14: 425–434
   Google Scholar
• Ball JC, Lange W, Myers C, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988; 29: 214–226
   PubMed Web of Science ®Google Scholar
• Marmor, M, Des Jarlais, DC, Cohen, H, et al. Risk factors for infection with Human Immunodeficiency Virus among intravenous drug users in New York City. AIDS 1987; 1: 39–44
   PubMed Web of Science ®Google Scholar
• Novick, DM, Joseph, H, Croxson, TS, et al. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch Intern Med 1990; 150: 97–99
   PubMed Web of Science ®Google Scholar
• Selwyn PA, Hartel D, Waisserman W, Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health 1989; 79: 1358–1362
   PubMed Web of Science ®Google Scholar
• Brown LS, Burkett W, Primm BJ. Drug treatment and HIV seropositivity. NY State J Med 1988; 88: 156–156
   PubMedGoogle Scholar
• Brown LS, Chu A, Nemoto T, Ajuluchukwu D, Primm BJ. Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City. Demographic, behavioural, and clinical features. NY State J Med 1989; 89: 506–510
   PubMedGoogle Scholar
• Weber R, Ledergerber B, Opravil M, Siegenthaler W, Luthy R. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br Med J 1990; 301: 1326–1365
   Google Scholar
• Buning EC, van Brussel GHA, van Santen G. Amsterdam's drug policy and its implications for controlling needle sharing. Needle sharing among intravenous drug abusers. National and international perspectives, RJ Battjes, RW Pickens. Natl Inst Drug Abuse Res Monogr Ser, 1988; 80: 59–74, In
   Google Scholar
• Hartgers C, van den Hoek JAR, Krijnen P, van Brussel GHA, Coutinho RA. Changes over time in heroin and cocaine use among injecting drug users in Amsterdam, The Netherlands, 1985–1989. Br J Addict 1991; 86: 1091–1097
   PubMedGoogle Scholar
• Van den Hoek JAR, van Haarstrecht HJA, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health 1989; 79: 1355–1357
   PubMed Web of Science ®Google Scholar
• Van Haarstrecht HJA, van den Hoek JAR, Bardoux C, Leentvaar-Kuypers A, Coutinho RA. The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands. Am J Public Health 1991; 81: 59–62
   PubMedGoogle Scholar
• Wolk J, Wodak A, Guinan JJ, Macaskill P, Simpson JM. The effect of a needle and syringe exchange on a methadone maintenance unit. Br J Addict 1990; 85: 1445–1450
   PubMedGoogle Scholar
• Resnick L, Veren K, Salahuddin SZ, Tondreau S, Markham PD. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 1986; 255: 1887–1891
   PubMed Web of Science ®Google Scholar
• Newmeyer JA. Why bleach? Development of a strategy to combat HIV contagion among San Francisco intravenous drug users. Needle sharing among intravenous drug abusers: national and internatinal perspectives, RJ Battjes, RW Pickens. Natl Inst Drug Abuse Res Monogr Ser, 1988; 80: 151–158, In
   Google Scholar
• Lishner DM, Look MS. Needle sharing practices and risk for AIDS transmission among intravenous drug users in Seattle. Intern J Addict 1990; 25: 1475–1483
   PubMed Web of Science ®Google Scholar
• Power R, Hartnoll R, Daviaud E. Drug injecting, AIDS, and risk behaviour: potential for change and intervention strategies. Br J Addict 1988; 83: 649–654
   PubMedGoogle Scholar
• Rahman MZ, Ditton J, Forsyth JM. Variations in needle sharing practices among intravenous drug users in Possil (Glasgow). Br J Addict 1989; 84: 923–927
   PubMedGoogle Scholar